In Vitro Fertilization Outcomes in Metabolic Syndrome

The Influence of Metabolic Syndrome on in Vitro Fertilization Treatment Outcome

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01958424

Enrollment

Registered

2013-10-09

Start date

2014-04-30

Completion date

2014-12-31

Last updated

2016-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Keywords

metabolic syndrome, in vitro fertilization, c reactive protein, over-weight women, ovarian stimulation

Brief summary

The purpose of this study is to examine the effect of metabolic syndrome in over-weight women on IVF treatment outcomes.

Detailed description

This porpuse of the study is to examine the physiology of CRP during the IVF cycle in and to evaluated the effect of CRP in patient with and without metabolic syndrome on IVF outcomes

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* women undergoing ivf treatment

Exclusion criteria

* inflammatory disease * acute conditions

Design outcomes

Primary

Measure	Time frame	Description
success or failure of ivf treatment	within 1 year from intiation of ivf treatment	success or failure of a treatment will be determined by beta-Human chorionic gonadotropin test, number of oocyte retrieved or fertilized and embryos quality.

Secondary

Measure	Time frame
blood levels of C-reactive protein	within 1 year from initiation of ivf treatment
follicle liquid levels of C-reactive protein	within 1 year from initiation of ivf treatment

Countries

Israel

Outcome results